Lyme disease: Stanford researchers say antibiotic, azlocillin, works well in mouse study

For decades, the routine treatment for Lyme disease has been standard antibiotics, which usually kill off the infection. But for up to 20% of people with the tick-borne illness, the antibiotics don't work, and lingering symptoms of muscle pain, fatigue and cognitive impairment can continue for years - sometimes indefinitely. A new Stanford Medicine study in lab ["]

The post Lyme disease: Stanford researchers say antibiotic, azlocillin, works well in mouse study appeared first on Outbreak News Today.